It is more than 15 years since the intellectual disabilities specialty was mired in controversy when data from California were reported, 1,2 which suggested higher rates of mortality among people with intellectual disabilities living in the community compared with those living in institutions. At the time, this fi nding was regarded as an attack on the movement of people with intellectual disabilities into the community, and there were criticisms of research quality 3 and eff orts to refute the fi ndings. 4 Over time, the fi ndings stood 5 and the methods used in studies to refute them were themselves challenged. 6 Subsequently, people started asking important questions about the role of communitybased primary care and community hospital care in supporting the lives of people with intellectual disabilities living in the community.
In The Lancet, Pauline Heslop and colleagues 7 report the results of the Confi dential Inquiry into premature deaths of people with intellectual disabilities in the UK. Rather than being a criticism of community placements, it draws attention to serious questions remaining long after the California study and, in a diff erent national context, about the quality of health care being off ered to people with intellectual disabilities in local communities, this time as compared with the general population.
The Confi dential Inquiry reviewed all deaths of people with intellectual disabilities who had been registered with a general practitioner in southwest England, and who died between June, 2010, and May, 2012. Deaths were described as avoidable, amenable (ie, could have been avoided in principle by medical knowledge and health care available at the time of death), or premature. Contributory factors were grouped into four domains: intrinsic to the individual, within the family and environment, care provision, and service provision. The deaths of a comparator group of people without intellectual disabilities but much the same in age, sex, and cause of death, and registered at the same general practices as those with intellectual disabilities, were also investigated.
Deaths of people with intellectual disabilities in the UK
The main question now is whether the trial by Kahn and colleagues 1 has given us a defi nitive answer on the usefulness of ECS for the prevention of PTS. Although this is the largest and only placebo controlled study so far, some questions remain. What are the individual contributions of the placebo eff ect, suboptimum compliance, and patient characteristics to the lack of eff ectiveness? A multicentre randomised trial comparing usual care (ECS for 2 years) with individualised care based on Villalta scores is in progress (ClinicalTrials.gov, NCT01429714). This future study will hopefully give additional information on some open questions: is there any benefi t of treatment with ECS, which patients benefi t most, and what is the optimum treatment duration? Methodology is important; in this report 7 the authors note that there was not a comprehensive register of people with intellectual disabilities to draw from. The lines between the general population and people with mild intellectual disabilities were blurred, and the comparator sample was not matched with the group of people with intellectual disabilities on socioeconomic status, as noted by the authors, or on any kind of baseline comorbidity index. 8 The samples involved were small and comparisons were associational rather than causal. It is of concern that our consideration of issues crucial to the lives of people with intellectual disabilities continues to be limited by methodological issues raised for decades; additional systematic and longitudinal work is needed 9 and must be supported by steps to ensure access to high-quality data.
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247 individuals with intellectual disabilities died during the study period; their median age was 64 years (IQR 52-75). Male individuals with intellectual disabilities died on average 13 years earlier than the population of England and Wales (median age at death 65 years [IQR 52-75] vs 78 years), and female individuals died on average 20 years earlier (63 years [54-75] vs 83 years). Avoidable deaths from causes amenable to change by good quality health care were more than twice as common in people with intellectual disabilities (37%, 90 of 244) than in the general population of England and Wales (13%). The fi ndings of the Confi dential Inquiry are not an aberration; premature death is well established. 10 Other fi ndings were that better quality health care would have reduced this elevated mortality. This latter fi nding is of particular importance because, rather than simply raising a concern, it off ers insight into next steps for exploring what must change if diff erent outcomes are to be achieved in the future.
These fi ndings beg the question of why such shortfalls in care are occurring. There are longstanding fi ndings of higher levels of chronic disorders in people with intellectual disability, and in particular increased mental health concerns. 11 Also, data from the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing 12 have shown diff erent patterns in multimorbidity, with eye disease and mental health problems most often associated with a second disorder, and mental health and neurological disease as the most prevalent multimorbidity pairing. In the Confi dential Inquiry report 7 such diff erences were further borne out in fi ndings of unaddressed or poorly addressed higher rates of nervous and congenital causes of death among people with intellectual disability. Those involved in community-based health care are probably neither aware of nor considering these health presentation diff erences for people with intellectual disabilities in the planning and implementation of health-care delivery. The fi ndings of the Confi dential Inquiry report not only raise concerns about individual care, but also question and challenge the organisation and responsiveness of health care when people with intellectual disabilities enter clinics, practices, and hospitals. There are educational challenges to be addressed for health-care practitioners. Additionally, providers of services for people with intellectual disabilities must examine how they can be more eff ective adjuncts and advocates working within community-based health care to minimise negative outcomes.
Finally, there is more to be known. Still to be established are eff ects from lower levels of unhealthy lifestyle choices, higher levels but diff erent patterns of chronic disorders, diff erential access and diff erential outcomes from health-care responses, and pre-existing lifelong disabilities and their roles as predictors and mediators of premature death. Such studies will require the ability to track incidence and prevalence of chronic conditions and related deaths. The need to improve the available data remains.
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In the fi rst few months of 2014, the UK media have already provided saturation coverage to mark a century since the outbreak of the First World War. Education Secretary for England Michael Gove had described it as a "just war"; others have recalled the words of the late Harry Patch, the last surviving veteran of the confl ict, who called it "legalised mass murder". There has been controversy over the necessity of the war itself, and of the form that commemoration should take. What can a medical journal add to this?
During the confl ict, The Lancet published papers on the diverse medical challenges of warfare-from surgery to psychiatry. This year, we would like to remember the war-and those who lost their lives, soldiers and civilians alike-by considering how it shaped and defi ned the challenges to human health of today's world. Massive social convulsions such as the First World War force both citizens and their leaders to face issues that would otherwise have been ignored or unaddressed. The role of the state in providing public health and health care; the rights of those with disabilities; the toll of mechanised warfare; the health impact of population movement: these are just some of the facets of human health that we will explore in a special issue later this year.
We invite submissions of relevant original research or review articles. Please submit your work via our online submission system, stating in your cover letter that the submission is in response to this call for papers. The deadline for submissions is June 30, 2014.
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